Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy

NCT06099951 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Serplulimab + FOLFOXIRI
RADIATION: Radiation therapy

Sponsor

Sun Yat-sen University